Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
Science Immunology · 02.09.2024 · 9 (92)
DOI: 10.1126/sciimmunol.adj9285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 02.09.2024. Verfasst von Helen R Wagstaffe und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Imperial College London, London, UK. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Human infection challenge permits in-depth, early, and pre-symptomatic characterization of the immune response, enabling the identification of factors that are important for viral clearance. Here, we performed intranasal inoculation of 34 young adult, seronegative volunteers with a pre-Alpha severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain. Of these participants, 18 (53%) became infected and showed an interferon-dominated mediator response with divergent kinetics between nasal and systemic sites. Peripheral CD4 + and CD8 + T cell activation and proliferation were early and robust but showed distinct kinetic and phenotypic profiles; antigen-specific T cells were largely CD38 + Ki67 + and displayed central and effector memory phenotypes. Both mucosal and systemic antibodies became detectable around day 10, but nasal antibodies plateaued after day 14 while circulating antibodies continued to rise. Intensively granular measurements in nasal mucosa and blood allowed modeling of immune responses to primary SARS-CoV-2 infection that revealed CD8 + T cell responses and early mucosal IgA responses strongly associated with viral control, indicating that these mechanisms should be targeted for transmission-reducing intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infectious Disease, Imperial College London, London, UK.
- National Heart and Lung Institute, Imperial College London, London, UK.
- Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
- UCL Division of Infection and Immunity, University College London, London, UK.
- Department of Infectious Diseases, University College London Hospital, London, UK.
- hVIVO Services Ltd., London, UK.
ORCID-Profile: Helen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, Stephanie Ascough, Loukas Papargyris, Ashley M Collins, Matthew K Siggins, Benny M Chain, Alex Mann, Andrew Catchpole, Miles P Davenport, Peter J M Openshaw, Christopher Chiu
Zitieren
APA
Wagstaffe, H. R., Thwaites, R. S., Reynaldi, A., Sidhu, J. K., McKendry, R., Ascough, S., Papargyris, L., Collins, A. M., Xu, J., Lemm, N. M., Siggins, M. K., Chain, B. M., Killingley, B., Kalinova, M., Mann, A., Catchpole, A., Davenport, M. P., Openshaw, P. J. M., & Chiu, C. (2024). Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Science Immunology, 9(92). https://doi.org/10.1126/sciimmunol.adj9285
Vancouver
Wagstaffe HR, Thwaites RS, Reynaldi A, Sidhu JK, McKendry R, Ascough S, et al. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Science Immunology. 2024;9(92). doi:10.1126/sciimmunol.adj9285
BibTeX
@article{Wagstaffe2024,
author = {Wagstaffe, Helen R and Thwaites, Ryan S and Reynaldi, Arnold and Sidhu, Jasmin K and McKendry, Richard and Ascough, Stephanie and Papargyris, Loukas and Collins, Ashley M and Xu, Jiayun and Lemm, Nana-Marie and Siggins, Matthew K and Chain, Benny M and Killingley, Ben and Kalinova, Mariya and Mann, Alex and Catchpole, Andrew and Davenport, Miles P and Openshaw, Peter J M and Chiu, Christopher},
title = {Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {92},
doi = {10.1126/sciimmunol.adj9285}
}
EUVIMED